Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

The genomics generation: heroes vs villains?

Kinney DD, Garrett D, Reynolds MW.

Public Health. 2013 Nov;127(11):975-7. doi: 10.1016/j.puhe.2013.09.021. Epub 2013 Nov 7. No abstract available.

PMID:
24210132
[PubMed - indexed for MEDLINE]
2.

Clinical outcomes of concomitant therapy of exenatide twice daily and basal insulin in patients with type 2 diabetes mellitus: a retrospective database analysis in the United States.

Pawaskar M, Li Q, Hoogwerf BJ, Reynolds MW, Lee LJ, Fonseca V.

Endocr Pract. 2012 Sep-Oct;18(5):700-11. doi: 10.4158/EP11367.OR.

PMID:
22982784
[PubMed - indexed for MEDLINE]
3.

Costs associated with febrile neutropenia in the US.

Michels SL, Barron RL, Reynolds MW, Smoyer Tomic K, Yu J, Lyman GH.

Pharmacoeconomics. 2012 Sep 1;30(9):809-23. doi: 10.2165/11592980-000000000-00000.

PMID:
22804805
[PubMed - indexed for MEDLINE]
4.

Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care setting.

Pawaskar M, Li Q, Reynolds MW.

Curr Med Res Opin. 2012 Jun;28(6):991-7. doi: 10.1185/03007995.2012.686901. Epub 2012 May 9.

PMID:
22519390
[PubMed - indexed for MEDLINE]
5.

Quality of life and economic costs associated with postthrombotic syndrome.

Kachroo S, Boyd D, Bookhart BK, LaMori J, Schein JR, Rosenberg DJ, Reynolds MW.

Am J Health Syst Pharm. 2012 Apr 1;69(7):567-72. doi: 10.2146/ajhp110241. Review.

PMID:
22441786
[PubMed - indexed for MEDLINE]
6.

Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.

Pawaskar M, Li Q, Hoogwerf BJ, Reynolds MW, Faries D, Engelman W, Bruhn D, Bergenstal RM.

Diabetes Obes Metab. 2012 Jul;14(7):626-33. doi: 10.1111/j.1463-1326.2012.01581.x. Epub 2012 Mar 8.

PMID:
22321776
[PubMed - indexed for MEDLINE]
7.

A systematic review of validated methods for identifying acute respiratory failure using administrative and claims data.

Jones N, Schneider G, Kachroo S, Rotella P, Avetisyan R, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:261-4. doi: 10.1002/pds.2326. Review.

PMID:
22262615
[PubMed - indexed for MEDLINE]
8.

A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data.

Jones N, Schneider G, Kachroo S, Rotella P, Avetisyan R, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:256-60. doi: 10.1002/pds.2338. Review.

PMID:
22262614
[PubMed - indexed for MEDLINE]
9.

A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data.

Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:248-55. doi: 10.1002/pds.2333. Review.

PMID:
22262613
[PubMed - indexed for MEDLINE]
10.

A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data.

Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:240-7. doi: 10.1002/pds.2327. Review.

PMID:
22262612
[PubMed - indexed for MEDLINE]
11.

A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data.

Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:236-9. doi: 10.1002/pds.2331. Review.

PMID:
22262611
[PubMed - indexed for MEDLINE]
12.

Guidelines for good database selection and use in pharmacoepidemiology research.

Hall GC, Sauer B, Bourke A, Brown JS, Reynolds MW, LoCasale R.

Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):1-10. doi: 10.1002/pds.2229. Epub 2011 Nov 8. Erratum in: Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1249. Casale, Robert Lo [corrected to LoCasale, Robert].

PMID:
22069180
[PubMed - indexed for MEDLINE]
13.

Trend analyses of insulin delivery systems in the United States.

Lee LJ, Li Q, Reynolds MW, Engelman W.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1116-23.

PMID:
22027304
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review.

Michels SL, Collins J, Reynolds MW, Abramsky S, Paredes-Diaz A, McCarberg B.

Curr Med Res Opin. 2012 Jan;28(1):89-99. doi: 10.1185/03007995.2011.633990. Epub 2011 Nov 28. Review.

PMID:
22017233
[PubMed - indexed for MEDLINE]
15.

Patient outcomes associated with 2-octyl cyanoacrylate topical skin adhesive in coronary artery bypass graft surgery.

Fraeman KH, Reynolds MW, Vaughn BB, Hart JC.

Surg Infect (Larchmt). 2011 Aug;12(4):307-16. doi: 10.1089/sur.2010.062.

PMID:
21859334
[PubMed - indexed for MEDLINE]
16.

Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims database.

Mercaldi CJ, Reynolds MW, Turpin RS.

JPEN J Parenter Enteral Nutr. 2012 May;36(3):330-6. doi: 10.1177/0148607111412974. Epub 2011 Jul 12.

PMID:
21750206
[PubMed - indexed for MEDLINE]
17.

Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients.

Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF, Hammond J.

BMC Health Serv Res. 2011 May 31;11:135. doi: 10.1186/1472-6963-11-135.

PMID:
21627788
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.

Lee LJ, Li Q, Reynolds MW, Pawaskar MD, Corrigan SM.

J Med Econ. 2011;14(1):75-86. doi: 10.3111/13696998.2010.546466. Epub 2011 Jan 13.

PMID:
21231863
[PubMed - indexed for MEDLINE]
19.

Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.

Mercaldi CJ, Ciarametaro M, Hahn B, Chalissery G, Reynolds MW, Sander SD, Samsa GP, Matchar DB.

Stroke. 2011 Jan;42(1):112-8. doi: 10.1161/STROKEAHA.110.592907. Epub 2010 Dec 9.

PMID:
21148442
[PubMed - indexed for MEDLINE]
Free Article
20.

Risk of mortality in patients with cancer who experience febrile neutropenia.

Lyman GH, Michels SL, Reynolds MW, Barron R, Tomic KS, Yu J.

Cancer. 2010 Dec 1;116(23):5555-63. doi: 10.1002/cncr.25332. Epub 2010 Aug 16.

PMID:
20715160
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk